These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31676702)

  • 1. A Case of Minimal Change Disease in a Patient with Rheumatoid Arthritis Treated with Certolizumab.
    Hwang SR; Sawatsky AP
    J Rheumatol; 2019 Dec; 46(12):1647. PubMed ID: 31676702
    [No Abstract]   [Full Text] [Related]  

  • 2. [Miller Fisher syndrome following treatment with certolizumab in a patient with rheumatoid arthritis].
    Alberola-Amores FJ; Navarro-Canto L; Gonzalez-Ferrandez JA
    Rev Neurol; 2017 Sep; 65(6):286-288. PubMed ID: 28896005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anaphylactic reaction by certolizumab in young woman with rheumatoid arthritis].
    Caballero-Requejo C; Monteagudo-González L; Urbieta-Sanz E
    Farm Hosp; 2018 May; 42(3):135-136. PubMed ID: 29730985
    [No Abstract]   [Full Text] [Related]  

  • 4. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
    Deeks ED
    BioDrugs; 2016 Dec; 30(6):607-617. PubMed ID: 27704400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoallergic Drug Eruption Caused by Certolizumab Pegol.
    Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Kabashima-Kubo R; Yoshioka M; Nisio D; Nakamura M
    Acta Derm Venereol; 2016 Jun; 96(5):710-1. PubMed ID: 26714785
    [No Abstract]   [Full Text] [Related]  

  • 6. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis.
    Nishimura A; Minegishi Y; Kwamura K; Ichino A; Uchiyama K
    Rheumatol Int; 2015 Sep; 35(9):1601-2. PubMed ID: 25645901
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis.
    Hynnekleiv L; Thrane AS; Krohn J
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33012711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
    Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewé R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
    Arthritis Res Ther; 2015 Sep; 17(1):245. PubMed ID: 26353833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis.
    Koizumi H; Tokuriki A; Oyama N; Ido H; Sugiura K; Akiyama M; Hasegawa M
    J Dermatol; 2017 Jun; 44(6):723-724. PubMed ID: 27599405
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece.
    Tzanetakos C; Tzioufas A; Goules A; Kourlaba G; Theodoratou T; Christou P; Maniadakis N
    Rheumatol Int; 2017 Sep; 37(9):1441-1452. PubMed ID: 28523420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report.
    Horai Y; Ishikawa H; Iwanaga N; Izumi Y; Matsuoka Y; Miura S; Kawakami A
    J Clin Pharm Ther; 2020 Oct; 45(5):1179-1182. PubMed ID: 31990069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous leishmaniasis mimicking dactylitis in a patient with rheumatoid arthritis treated with certolizumab.
    Herrerias-Moreno J; Expósito-Serrano V; Agut-Busquet E; Corbacho M; Sáez E; Luelmo J
    Clin Exp Dermatol; 2018 Apr; 43(3):348-350. PubMed ID: 29218754
    [No Abstract]   [Full Text] [Related]  

  • 15. Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Rutherford AI; Subesinghe S; Hyrich KL; Galloway JB
    Ann Rheum Dis; 2018 Jun; 77(6):905-910. PubMed ID: 29592917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.
    Migita K; Tsuji Y; Hisatomi K; Shigeno R; Izumi Y; Iwanaga N; Koga T
    Mod Rheumatol; 2017 Nov; 27(6):1079-1082. PubMed ID: 26044288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
    Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME
    Ann Rheum Dis; 2017 Jan; 76(1):96-104. PubMed ID: 27165179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis.
    Kang YM; Park YE; Park W; Choe JY; Cho CS; Shim SC; Bae SC; Suh CH; Cha HS; Koh EM; Song YW; Yoo B; Lee SS; Park MC; Lee SH; Arendt C; Koetse W; Lee SK
    Korean J Intern Med; 2018 Nov; 33(6):1224-1233. PubMed ID: 29294598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Certolizumab pegol was effective for treating residual synovitis after total knee arthroplasty in a patient with rheumatoid arthritis: therapeutic monitoring by ultrasound.
    Kawashiri SY; Michitsuji T; Kawakami A
    J Med Ultrason (2001); 2018 Apr; 45(2):371-374. PubMed ID: 28725981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.
    Cauli A; Piga M; Lubrano E; Marchesoni A; Floris A; Mathieu A
    J Rheumatol Suppl; 2015 Nov; 93():70-2. PubMed ID: 26523062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.